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Ppm1b negatively regulates necroptosis through
dephosphorylating Rip3
Wanze Chen1, Jianfeng Wu1, Lisheng Li1, Zhengmao Zhang2,3, Junming Ren1, Yaoji Liang1, Fenfang Chen2,
Chao Yang1, Zhenru Zhou1, Sheng Sean Su1, Xinru Zheng1, Zhirong Zhang1, Chuan-Qi Zhong1, Haoqiang Wan1,
Mu Xiao2, Xia Lin3, Xin-Hua Feng2,3 and Jiahuai Han1,4
The auto-phosphorylation of murine receptor-interacting protein 3 (Rip3) on Thr 231 and Ser 232 in the necrosome is required to
trigger necroptosis. However, how Rip3 phosphorylation is regulated is still largely unknown. Here we identified protein
phosphatase 1B (Ppm1b) as a Rip3 phosphatase and found that Ppm1b restricts necroptosis in two settings: spontaneous
necroptosis caused by Rip3 auto-phosphorylation in resting cells, and tumour necrosis factor-α (TNF)-induced necroptosis in
cultured cells. We revealed that Ppm1b selectively suppresses necroptosis through the dephosphorylation of Rip3, which then
prevents the recruitment of mixed lineage kinase domain-like protein (Mlkl) to the necrosome. We further showed that Ppm1b
deficiency (Ppm1bd/d) in mice enhanced TNF-induced death in a Rip3-dependent manner, and the role of Ppm1b in inhibiting
necroptosis was evidenced by elevated Rip3 phosphorylation and tissue damage in the caecum of TNF-treated Ppm1bd/d mice.
These data indicate that Ppm1b negatively regulates necroptosis through dephosphorylating Rip3 in vitro and in vivo.
Necroptosis is a kind of programmed necrosis that relies on the
receptor-interacting serine/threonine kinase 1 (Rip1) andRip3 (ref. 1),
although Rip1 is dispensable in some conditions2–4. It has been found
to be involved in many physiological and pathological processes,
such as host defence against viruses, inflammation, tissue injury,
eye diseases and cancers5,6. Although necroptosis can be triggered
by various stimuli, our knowledge on the necroptotic pathway
is mainly obtained through the study of that induced by TNF.
Under TNF stimulation, a multiple protein complex (termed the
necrosome) forms to initiate necroptosis1. Rip1 and Rip3 are the
core components in the necrosome and interact through their RIP
homotypic interaction motif7–11 (RHIM). Rip3 in the necrosome
recruits and phosphorylates the pseudokinase Mlkl (refs 12–14). The
phosphorylated Mlkl translocates to the cytomembrane to execute
necroptosis15–18. The phosphorylation of Rip3 (Thr 231 and Ser 232
inmouse Rip3; Ser 227 in human Rip3) is essential for the recruitment
of Mlkl to the necrosome13,19. Here we identified Ppm1b as a Rip3
phosphatase and showed that Ppm1b suppressed necroptosis both in
culture cells and in vivo by dephosphorylating Rip3.
RESULTS
Identification of Ppm1b as a Rip3 phosphatase
As a result of the requirement of Rip3 auto-phosphorylation in
necroptosis13,19, we searched for Rip3 phosphatase(s) that regulate
Rip3 phosphorylation. By mass spectrometry analysis of murine Rip3
immunocomplexes, we identified five phosphatases, Ppm1b, protein
phosphatase 1G (Ppm1g), serine/threonine-protein phosphatase 5
(Ppp5c), dual-specificity phosphatase 3 (Dusp3) and tyrosine-
protein phosphatase non-receptor type 2 (Ptpn2; Supplementary
Table 1). The three known proteins in the Rip3 complex including
Rip1, FAS-associated death domain protein (Fadd) and Mlkl were
found in the immunocomplexes, so these phosphatases could be
Rip3-interacting proteins. As Rip3 underwent auto-phosphorylation
when overexpressed in 293T cells19, we coexpressed each of these
phosphatases with Rip3 in 293T cells to evaluate their phosphatase
activity towards Rip3 and found that Ppm1b but not the other
phosphatases reduced the phosphorylation of Rip3 (Fig. 1a).
There are seven splicing variants of murine Ppm1b encoding
four proteins with different carboxy-terminal sequences. Splicing
variants encoding isoform 1 (relative molecular mass 55,000 (Mr55K),
termed Ppm1b-L) and isoform 2 (Mr55K, termed Ppm1b-S) are
expressed ubiquitously20–22. The Ppm1b complementary DNA used
in the above experiments encodes Ppm1b-L. Ppm1b-S is also capable
of lowering Rip3 phosphorylation in a dose-dependent manner
(Fig. 1b). The phosphatase dead mutant of Ppm1b (R179G, Arg 179
to glycine mutation23) failed to reduce the phosphorylation of Rip3,
confirming that Ppm1b is a phosphatase of Rip3 (Fig. 1c). The data
obtained by using bacterially expressed recombinant GST–Ppm1b-L
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Figure 1 Identification of Ppm1b as a Rip3 phosphatase. (a) Ppm1b
dephosphorylates Rip3 in 293T cells. Rip3 was coexpressed with or without
increasing amounts of phosphatases in 293T cells. The cells were lysed
and immunoblotted with the indicated antibodies 36h post transfection.
The vertical line represents a splice mark. The samples were obtained
and processed in the same experiment, and the gels/blots were processed
in parallel. (b) Both Ppm1b-L and Ppm1b-S dephosphorylate Rip3 in a
dose-dependent manner. Rip3 was coexpressed with or without increasing
amounts of Ppm1b-S and Ppm1b-L in 293T cells. The cells were lysed
and immunoblotted with the indicated antibodies 36h post transfection.
(c) Ppm1b phosphatase activity is required for dephosphorylating Rip3.
Rip3 was coexpressed with or without increasing amounts of Ppm1b-L
and its phosphatase-deficient mutant R179G in 293T cells. The cells
were analysed as in b. The vertical line represents a splice mark. The
spliced images were from the same blot. (d) Ppm1b dephosphorylates
Rip3 in vitro. Flag–Rip3 (purified from 293T cells) was incubated with
recombinant GST–Ppm1b-L, GST–R179G and GST–vector in vitro. The
phosphorylated Rip3 and total Rip3 were detected by immunoblotting with
the indicated antibodies. Recombinant Ppm1b and R179G were shown
by Coomassie blue staining. Data shown are representative of two or
more independent experiments. Uncropped images of blots are shown in
Supplementary Fig. 7.
and GST–R179Gmutant demonstrated that Ppm1b dephosphorylates
Rip3 directly (Fig. 1d).
Ppm1b is likely to associate with Rip3 in resting cells because we
can detect its interaction with Rip3 in L929 cells (Supplementary
Fig. 1a) and when the two proteins were coexpressed in 293T cells
(Supplementary Fig. 1b). The interaction is specific as Ppm1b interacts
with Rip3 but not the other proteins involved in the necroptosis,
such as Fadd, caspase-8, Mlkl or Rip1 (Supplementary Fig. 1c).
Ppm1b contains an amino-terminal phosphatase domain (PD) and
a C-terminal domain (CD; Supplementary Fig. 1d). Whereas the
CD was suggested to determine the substrate specificity of Ppm1b
(ref. 23), we found that PD is responsible for the interaction
with Rip3 (Supplementary Fig. 1e). We also found that the kinase
domain (KD) of Rip3 is responsible for its interaction with Ppm1b
(Supplementary Fig. 1f).
Ppm1b protects cells from Rip3-dependent spontaneous
necroptosis
Both Ppm1b-L and Ppm1b-S are expressed in L929, a cell line com-
monly used in studying TNF-induced necroptosis (Supplementary
Fig. 2a). Knockdown of Ppm1b by short hairpin RNAs (shRNAs;
targeting both L and S isoforms, Supplementary Fig. 2a) increased
spontaneous cell death (Fig. 2a). Different L929 sublines vary in their
sensitivity to zVAD-induced cell death24. To avoid zVAD-induced
cell death, we used a L929 line that resists zVAD-induced death to
determine whether the spontaneous cell death is caspase-dependent.
The spontaneous cell death is not dependent on caspase activity
or Rip1 kinase activity, as neither general caspase inhibitor zVAD
nor Rip1 kinase inhibitor necrostatin-1 (Nec-1; ref. 25) blocked the
cell death (Fig. 2b). Ppm1b-L and Ppm1b-S seemed to have an ad-
ditive effects because the spontaneous cell death became obvious
only in Ppm1b-L and Ppm1b-S double-knockdown cells (Supple-
mentary Fig. 2b). Unless specifically indicated, Ppm1b knockdown
in the rest of our studies refers to knockdown of both Ppm1b-L
and Ppm1b-S.
We next examined the effect of Ppm1b knockdown on cell
viability in a panel of different types of cell. Knockdown of Ppm1b
in primary peritoneal macrophages (Mφ), macrophage cell line
J774, NIH3T3-N (ref. 8), mouse embryonic fibroblast (MEF) and
HT29 cells (Supplementary Fig. 2c) increased spontaneous cell
death (Fig. 2c), but had no effect on cell death in NIH3T3-
A (ref. 8) and HeLa cells (Fig. 2c and Supplementary Fig. 2c).
As NIH3T3-A and HeLa cells lack Rip3 expression, whereas all
the others express Rip3 (ref. 8; Fig. 2d), the Ppm1b knockdown-
mediated increase of spontaneous cell death seems to be dependent
on the presence of Rip3. Meanwhile, using transmission electron
microscopy, we found necrotic morphology in Ppm1b knockdown-
induced death of L929,Mφ, J774, NIH3T3-N andHT29 cells (Fig. 2e).
Furthermore, Ppm1b knockdown (Supplementary Fig. 2d,e) increased
spontaneous cell death in WT but not Rip3 KO L929 and Mφ cells
(Fig. 2f,g), confirming that Ppm1b knockdown-mediated cell death
is Rip3-dependent.
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Figure 2 Ppm1b protects cells from Rip3-dependent spontaneous
necroptosis. (a) Ppm1b was knocked down by lentivirus-delivered shRNAs
targeting both the Ppm1b-L and Ppm1b-S isoforms in L929 cells. Forty-
eight hours after infection, the cells were stained with propidium iodide
(PI) and analysed under a microscope. Dead cells were PI positive. Scale
bar, 100 µm. shScramble: non-target control shRNA. The protein expression
levels are shown in Supplementary Fig. 2a. (b) Ppm1b was knocked down by
lentivirus-delivered shRNA in L929 cells. Six hours after infection, these cells
were treated with DMSO, zVAD (20 µM) and Nec-1 (30 µM). Spontaneous cell
death was analysed by PI staining under a microscope 48h later. n=3,000
cells pooled from three independent experiments. (c) Ppm1b was knocked
down in different mouse and human cell lines. Spontaneous cell death was
counted by PI staining under a microscope 48h (72h for Mφ and J774) later.
Mφ: mouse peritoneal macrophage. The protein expression levels are shown
in Supplementary Fig. 2c. n=3,000 cells pooled from three independent
experiments. (d) The Rip3 expression level correlates with the cell death
caused by Ppm1b knockdown in the cells analysed in c. (e) The morphology
of Ppm1b knockdown-induced spontaneous dead cells was analysed by
transmission electron microscopy. Scale bar, 2 µm. TNF-induced necroptosis
in L929 cells and TNF-induced apoptosis in Rip1 KO L929 cells were
included as a control. (f,g) Ppm1b was knocked down in WT, Rip3 KO
L929 cells (f) and WT, Rip3 KO Mφ (g). Then, spontaneous cell death was
analysed. n=3,000 cells pooled from three independent experiments. The
protein expression levels are shown in Supplementary Fig. 2d,e. For b,c,f,g,
results shown are mean ± s.e.m.; #P<0.05, ##P<0.01, ###P<0.001. For
a,d,e data shown are representative of two or more independent experiments.
Statistics source data for this figure can be found in Supplementary Table 2.
Uncropped images of blots are shown in Supplementary Fig. 7.
Ppm1b prevents Rip3 auto-activation in resting cells
We addressed whether knockdown of Ppm1b would increase the
basal phosphorylation level of Rip3. Rip3 was immunoprecipitated
fromWT and Ppm1b knockdown L929 cells, and its phosphorylation
level was measured by immunoblotting with anti-phospho-Rip3
antibody. Rip3 phosphorylation was indeed increased in Ppm1b
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Figure 3 Ppm1b prevents Rip3 auto-activation and it mediated spontaneous
necroptosis. (a) Endogenous Rip3 was immunoprecipitated with anti-Rip3
antibody in Ppm1b knockdown and control cells. The immunoprecipitates
were treated with or without λ-Ppase and subsequently immunoblotted with
the indicated antibodies. (b) Rip3 KO L929 cells reconstituted with Rip3-WT,
Rip3-2A and Rip3RHIM mutants were infected with Ppm1b or control shRNA.
Spontaneous necroptosis was analysed. Protein expression levels are shown
in Supplementary Fig. 3a. (c) Ppm1b knockdown-induced spontaneous cell
death in WT and Rip1 KO L929 cells was analysed. Protein expression levels
are shown in Supplementary Fig. 3b. (d) WT Rip3, Rip3RHIM and empty
vector were introduced into WT and Rip1 KO L929 by lentiviral vectors.
Necroptosis was analysed 24h later. Protein expression levels are shown in
Supplementary Fig. 3c. (e) FKBP–Rip3RHIM and FRB–Rip3RHIM mutants were
introduced into Rip1–Rip3 DKO L929 and forced to interact with each other
by treatment of dimerizer AP21967; subsequent cell death was analysed
(see Methods). (f,g) Cells expressing FKBP–Rip3RHIM and FRB–Rip3RHIM were
infected with lentiviral vector encoding Ppm1b (co-infection of Ppm1b-L
and Ppm1b-S) or with empty vector, or treated with zVAD (20 µM). Twenty-
four hours later, cells were treated with or without AP21967 (250nM)
for 2 h. (f) cells were then lysed and immunoblotted; (g) cell death was
analysed. (h) Ppm1b knockdown-induced spontaneous cell death in WT and
Mlkl KO L929 cells was analysed. Protein expression levels are shown in
Supplementary Fig. 3d. (i) Mlkl KO L929 cells expressing Mlkl–HBD were
analysed as in g, except that 4-OHT (1 µM) rather than AP21967 was used
to induce Mlkl oligomerization-mediated cell death. For b–e,g–i, results
shown are mean ± s.e.m.; n=3,000 cells pooled from three independent
experiments; ##P<0.01, ###P<0.001. For a,f, data shown are representative
of two or more independent experiments. The asterisk denotes a nonspecific
band. Statistics source data for this figure can be found in Supplementary
Table 2. Uncropped images of blots are shown in Supplementary Fig. 7.
knockdown cells (Fig. 3a). The specificity of the phospho-Rip3
antibody was confirmed by immunoblotting with the samples treated
with λ-phosphatase (λ-Ppase). Reintroducing Rip3 WT but not the
Rip3 phosphorylation-deficient mutant (Thr 231 and Ser 232mutated
to alanine, termed Rip3-2A) into Rip3 KO L929 cells restored the
sensitivity of L929 cells to Ppm1b depletion-induced necroptosis
(Fig. 3b and Supplementary Fig. 3a), indicating that the upregulation
of Rip3 phosphorylation corresponds to spontaneous necroptosis.
Reintroducing the Rip3 RHIM domain mutant (QIG449-451AAA
mutation in RHIM, termed Rip3RHIM) to Rip3 KO L929 cells cannot
rescue the spontaneous necroptosis (Fig. 3b and Supplementary
Fig. 3a), suggesting that the RHIM-mediated Rip3 interaction
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Figure 4 Ppm1b negatively regulates TNF-induced necroptosis. (a,b) L929
cells were infected with Ppm1b or control shRNA. Forty-eight hours later,
spontaneous dead cells were removed by re-plating the cells. (a) These
cells were then treated with or without TNF (10ngml−1) for 5 h. Cell death
was analysed by flow cytometer; n=3 independent experiments. (b) These
cells were treated with TNF for the indicated time and then analysed by
immunoblotting. (c) TNF-induced necroptosis was analysed in Ppm1b KO
(n=7 clones) and WT (n=8 clones) L929 cells. n is representative of a
single experiment where two independent experiments were performed to
assess reproducibility. (d) Ppm1b KO L929 cells were reconstituted with
Ppm1b-L, Ppm1b-S, both isoforms or the R179Gmutants. Left, TNF-induced
necroptosis was analysed. n=3 independent experiments. R179G (L+S):
Ppm1b-L R179G and Ppm1b-S R179G mutants. Right, cell lysates were
immunoblotted. (e) Ppm1b KO L929 cells reconstituted with Ppm1b or its
mutants were treated with TNF for the indicated time. Then cell lysates were
immunoblotted. (f) Ppm1d/d mice with a gene-trap vector inserted in the
second intron of Ppm1b genomic locus. (g) Cell lysates of primary Ppm1bd/d
and WT MEF cells were immunoblotted. (h) The immortalized Ppm1bd/d
and WT MEF cells were treated with TNF (30ngml−1) plus zVAD (20 µM)
for the indicated time. Left, cell death was analysed. n=3 independent
experiments. Right, cell lysates were immunoblotted. (i) Ppm1bd/d and
WT MEF cells were treated with TNF (30ngml−1) plus Smac mimetic
(Smac; 100nM) for the indicated time. Then apoptosis was measured
by Annexin V staining. n= 3 independent experiments. (j) BMDMs from
Ppm1bd/d and WT mice were treated with poly(I:C) (100 µgml−1) plus zVAD
(20 µM) for the indicated time, and then cell death was analysed. n=3
independent experiments. For a,c,d,h–j, results shown are mean ± s.e.m.;
NS: no significant difference, #P < 0.05, ##P < 0.01, ###P < 0.001. For
b,e,g,h, data shown are representative of two independent experiments.
The asterisk denotes a nonspecific band. Statistics source data can be
found in Supplementary Table 2. Uncropped images of blots are shown in
Supplementary Fig. 7.
is essential for the spontaneous necroptosis. Rip3 also interacts
with Rip1 through its RHIM (ref. 26), but Ppm1b knockdown
increased spontaneous death in Rip1 KO L929 cells to a level similar
to that observed in WT L929 cells (Fig. 3c and Supplementary
Fig. 3b), indicating that Ppm1b depletion-induced spontaneous
necroptosis is not Rip1-dependent. This is consistent with the
data of Nec-1 treatment (Fig. 2b). As RHIM is essential for Rip3
overexpression-induced Rip1-independent cell death process
(Fig. 3d and Supplementary Fig. 3c), we examined whether RHIM
is directly required for targeting Rip3 by Ppm1b. We expressed
FK506 binding protein (FKBP)-fused Rip3RHIM (FKBP–Rip3RHIM)
and FKBP–rapamycin binding domain (FRB)-fused Rip3RHIM
(FRB–Rip3RHIM) in Rip1–Rip3 double knockout cells by lentiviral
vectors27 and created RHIM-independent Rip3 homo-interaction
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Figure 5 Ppm1b suppresses Mlkl recruitment to the necrosome under TNF
stimulation. (a–c) 293T cells were transfected with the plasmids as indicated.
Cell lysates were immunoprecipitated with anti-HA antibody (IP: HA) or anti-
Myc antibody (IP: Myc). The lysates (Input) and immunoprecipitates were
immunoblotted. (d) Ppm1b was knocked down in Rip3-KO–Flag–Rip3 L929
cells, and then the cells were treated with TNF (10ngml−1) for the indicated
time. The necrosome was analysed by immunoprecipitation with anti-Flag
antibody (IP: Flag). The cell lysates (Input) and immunocomplexes were
analysed by immunoblotting with the indicated antibodies. (e) Rip3-KO–Flag–
Rip3 L929 cells were treated with TNF for the indicated time. The cell lysates
were immunoprecipitated with anti-HA (IP: HA) and anti-Flag (IP: Flag)
antibodies and analysed by immunoblotting with the indicated antibodies.
The vertical line represents a splice mark. The samples were obtained and
processed in the same experiment, and the gels/blots were processed in
parallel, except that the exposure time of Ppm1b for the immunoprecipitates
is ten times that for the input. (f) L929 cells expressing Flag–Ppm1b-L
were treated with or without TNF for 6 h. Then cells were subjected to
subcellular fractionation (see Methods). Each fraction was subjected to
immunoblotting with the indicated antibodies. TCL: total cell lysate; S600:
supernatant fraction after centrifugation at 600g ; HM: heavy membrane
fraction; HeteroM: heterotypic membrane fraction. Canx: ER marker. Data
shown are representative of two or more independent experiments. The
arrowhead denotes the heavy chain and the asterisk denotes a nonspecific
band. Uncropped images of blots are shown in Supplementary Fig. 7.
by the addition of AP21967 to induce interaction of FKBP and FRB
(Fig. 3e). This RHIM-independent Rip3–Rip3 interaction drove the
auto-phosphorylation of Rip3 (Fig. 3f), and Ppm1b still attenuated
the phosphorylation level (Fig. 3f) and blocked the cell death (Fig. 3g).
Mlkl is a downstream effector of Rip3 in the necroptosis
pathway12–15,17,18,28 and we confirmed that Ppm1b knockdown did
not increase spontaneous cell death in Mlkl KO cells (Fig. 3h and
Supplementary Fig. 3d). Consistently, the cell death caused by the
hormone binding domain of oestrogen receptor (HBD)-mediated
oligomerization of the Mlkl–HBD fusion protein17 cannot be affected
by Ppm1b (Fig. 3i). We also excluded a role of TNF autocrine29 in
Ppm1b depletion-induced spontaneous necroptosis by using TNFR1
KOL929 (ref. 30; Supplementary Fig. 3e). Collectively, our data suggest
that the spontaneous cell death is initiated by Rip3 RHIM-mediated
auto-activation and its downstreammechanism ismost likely the same
as TNF-induced necroptosis.
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Figure 6 Ppm1a does not negatively regulate necroptosis. (a–c) Ppm1a
was knocked down in L929 cells. (a) Forty-eight hours later, spontaneous
cell death was measured; n=3,000 cells pooled from three independent
experiments. (b) The cells were treated with or without TNF (10ngml−1)
for 6 h and cell death was analysed by flow cytometer; n=3 independent
experiments. (c) The cell lysates were immunoblotted with the indicated
antibodies. (d) Ppm1a KO L929 cells were generated by CRISPR/Cas9
technology. Ppm1a KO (n = 8 clones) and WT (n = 8 clones) L929
were treated with or without TNF. Then cell death was analysed. n is
representative of a single experiment where two independent experiments
were performed to assess reproducibility. (e–g) Ppm1a does not compensate
for Ppm1b in restricting necroptosis. Ppm1a and Ppm1b were knocked
down respectively or together. (e) Forty-eight hours later, spontaneous cell
death was recorded; (f) the cells were treated with or without TNF and
then cell death was analysed; (g) the cell lysates were immunoblotted
with the indicated antibodies. n=3 independent experiments. (h) Different
subcellular localization of Ppm1a and Ppm1b. L929 cells were treated with
or without TNF for 6 h. Then nucleus and cytosol fractions of the cells
were isolated by subcellular fractionation. These fractions were analysed by
immunoblotting with the indicated antibodies. N: nucleus fraction; C: cytosol
fraction; H3: Histone H3, a nucleus marker; Gapdh: a cytosol marker. For
a,b,d–f, results shown are mean ± s.e.m.; ##P <0.01; ###P <0.001. For
c,g,h, data shown are representative of two or more independent experiments.
The asterisk denotes a nonspecific band. Statistics source data can be
found in Supplementary Table 2. Uncropped images of blots are shown in
Supplementary Fig. 7.
Ppm1b negatively regulates TNF-induced necroptosis
AsRip3 phosphorylation is required for TNF-induced necroptosis13,19,
we next investigated whether Ppm1b affects TNF-induced
necroptosis. The dead cells caused by spontaneous death in
culture were removed before the analyses (see Methods). Compared
with the control, knockdown of Ppm1b enhanced TNF-induced
necroptosis in L929 cells (Fig. 4a and Supplementary Fig. 4a,b).
This enhanced necroptosis correlates with the increase of Rip3
phosphorylation in L929 cells (Fig. 4b). In contrast, knockdown of
Ppm1b in NIH3T3-A cells did not affect TNF-induced apoptosis
(Supplementary Fig. 4c). Both Ppm1b-L and Ppm1b-S are important
in this process as knockdown of either of them exhibited a less
enhancing effect than double knockdown (Supplementary Fig. 4d).
We knocked out the Ppm1b gene in L929 cells and selected a number
of Ppm1b knockout lines. As controls, we also isolated several
Ppm1b-expressing colonies during the process of knocking out
Ppm1b. Perhaps owing to the growth selection in culture, none
of the Ppm1b KO lines showed a higher level of spontaneous cell
death than control L929 cells. However, Ppm1b knockout cells were
more sensitive to TNF-induced cell death (Fig. 4c). Reconstitution
of either Ppm1b-L or Ppm1b-S expression in Ppm1b KO cells
attenuated TNF-induced cell death, and re-expression of both of
them led to a severe inhibitory effect on TNF-induced cell death,
but re-expression of R179G mutants showed no difference from
the control (Fig. 4d). It seemed that these two Ppm1b isoforms
exhibited no functional difference in inhibiting necroptosis and
the inhibitory effect was decided by their overall expression level.
We observed that the infection of L929 cells with 10 moi virus
encoding Ppm1b-L (L) + 10 moi virus encoding Ppm1b-S (S)
(20 moi in total) had a similar effect to the infection with 20 moi
L or 20 moi S alone (Supplementary Fig. 4e); and the infection of
L929 cells with 20 moi L + 20 moi S had a stronger effect than
that with 20 moi L or S alone (Supplementary Fig. 4e). The level of
TNF-induced Rip3 phosphorylation in Ppm1b-reconstituted L929
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Figure 7 Ppm1b protects mice from TNF-induced SIRS through
dephosphorylating Rip3. (a) Ppm1bd/d , Ppm1bd/+ and WT mice raised as
littermates were injected with 15 µg TNF through the tail vein. Mouse survival
is presented as a Kaplan–Meyer plot and log-rank test was performed.
n=13 mice for each group pooled from three independent experiments.
Ppm1bd/d versus WT, P < 0.001. (b) WT, Ppm1bd/d , Ppm1b+/+ Rip3−/−
and Ppm1bd/d Rip3−/− mice were analysed as in a. n=6 mice of a single
experiment where two independent experiments were performed to assess
reproducibility. (c,d) Caecum of WT and Rip3−/− mice injected with TNF for
the indicated time was sectioned and stained with H&E. The representative
images are shown in c. At the 6 h time point, n=10 mice for each group.
At other time points, n=4 mice. Original magnification: ×200; scale bar,
100 µm. The TNF-induced caecum damage at the 6 h time point was scored
(see Methods) and is shown in d. n is representative of a single experiment
where two independent experiments were performed to assess reproducibility.
Wilcoxon signed-rank test, P <0.01. (e,f) Sections of the caecum of WT
and Ppm1bd/d mice were analysed as in c,d. Wilcoxon signed-rank test,
P=0.012. (g) WT and Ppm1bd/d mice were injected with PBS or TNF (15 µg)
for 6 h. Then the caecum was collected and lysed. Rip3 protein was enriched
from the lysate through immunoprecipitation and subsequently subjected to
immunoblotting with p-Rip3 and Rip3 antibodies. A Rip3−/− mouse was used
as a negative control (negative CTRL). (h,i) WT, Ppm1bd/d , Ppm1b+/+Rip3−/−
and Ppm1bd/dRip3−/− mice were injected with TNF for 6 h and subsequently
analysed as in c,d, except that n= 7 mice for each group of a single
experiment where two independent experiments were performed to assess
reproducibility; Wilcoxon signed-rank test; NS: no significant difference.
Statistics source data for this figure can be found in Supplementary Table 2.
Uncropped images of blots are shown in Supplementary Fig. 7.
cells was lower than in control cells (Fig. 4e), but the level in Ppm1b
R179G mutant-expressing cells was not (Fig. 4e), supporting the
role of Ppm1b in dephosphorylating Rip3. Importantly, Ppm1b is
specific for TNF-induced phospho-Rip3 dephosphorylation in L929
cells, as Ppm1b knockdown had no effect on TNF-induced p65 and
p38 phosphorylation (Supplementary Fig. 4f). Together, these data
demonstrate that Ppm1b dephosphorylates Rip3 and thus negatively
regulates TNF-induced necroptosis in L929 cells.
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As Ppm1b KO mouse is pre-implantation lethal31, we generated
a Ppm1b gene-trap mouse line (Ppm1b+/d ) using embryonic stem
cells containing a retroviral gene trap in the second intron of the
Ppm1b locus (Fig. 4f). The insertion resulted in the expression of a
Ppm1b–β-galactosidase-neomycin (β-geo) fusion protein containing
1–282 amino acids of Ppm1b, which lacks a functional phosphatase
domain (1-300 amino acids; Supplementary Fig. 4g) and thus is a loss-
of-function mutant. The Ppm1bd/d mice are viable and born with a
normalMendelian distribution. The normal development ofPpm1bd/d
mice is due to the expression of a small amount of wild-type Ppm1b
because we detected Ppm1b-L and Ppm1b-S protein in MEF cells
isolated from Ppm1bd/d mice (Fig. 4g). The expression of Ppm1b
most probably resulted from the splicing out of the intron in which
the retroviral vector inserts. Similar to what was observed in L929
cells, Ppm1bd/d MEF cells are more sensitive to TNF+ zVAD-induced
Rip3 phosphorylation and necroptosis (Fig. 4h). It was reported that
kinase dead Rip3 promotes Rip1-dependent apoptosis in mice and
MEF cells32.We questionedwhether Ppm1b regulates Rip1-dependent
apoptosis and found that TNF plus Smac mimetic (Smac)-induced
apoptosis33,34 in Ppm1bd/d and WT MEF cells were comparable
(Fig. 4i). It should be mentioned that the dephosphorylation of Rip3
should not affect the kinase activity of Rip3 because mutation of
the phosphorylation sites (Thr 231 and Ser 232 to alanine) did not
affect the kinase activity of Rip3 (ref. 19). We also found that Ppm1b
knockdown enhanced poly(I:C)+zVAD-induced necroptosis of bone
marrow-derived macrophages (BMDMs; Fig. 4j).
The regulation of necroptosis by Ppm1b is independent of the
NF-κB pathway
Ppm1b can dephosphorylate inhibitor of nuclear factor κ-B kinase
subunit β (IKKβ) and negatively regulate NF-κB activation in HeLa
cells35 (Supplementary Fig. 5a). However, the knockdown of Ppm1b
in L929 cells (Supplementary Fig. 4f) and HT29 cells (Supplementary
Fig. 5b) did not affect NF-κB p65 phosphorylation. TNF-induced
interleukin 6 (IL-6) production was also not influenced by Ppm1b
knockdown in L929 cells (Supplementary Fig. 5c). Thus, Ppm1b
regulates NF-κB in some but not all types of cell. Using the IKKβ
inhibitors TPCA-1 (ref. 36) and IMD 0354 (ref. 37), and an IKKβ
knockout L929 line, we showed that the role of Ppm1b in necroptosis
has no linkage to IKKβ (Supplementary Fig. 5d,e,f). TGF-β activated
kinase 1 (TAK1) was also reported to be dephosphorylated by Ppm1b
(ref. 38). However, Ppm1b knockdown still enhanced TNF-induced
necroptosis in the presence of the TAK1 inhibitor 5Z-7-oxozeaenol
(5z-7; ref. 39; Supplementary Fig. 5g). NF-κB activation is known to
play a pro-survival role in TNF-stimulated cells, which was also the
result we saw here in that the IKKβ and TAK1 inhibition or depletion
increased cell death in TNF-treated cells (Supplementary Fig. 5e,g).
However, our data demonstrate that the regulation of necroptosis by
Ppm1b is independent of the NF-κB pathway.
As Ppm1b inhibits IKKβ in HeLa but not in L929 and HT-29 cells,
and Rip3 is expressed in L929 and HT-29 but not in HeLa (Fig. 2d),
one would ask whether the presence of Rip3 makes Ppm1b unable
to target IKKβ. We used HeLa-hRip3 (HeLa cells stably expressing
human Rip3) to address this question. Similar to that in control HeLa
cells (Supplementary Fig. 5a), the knockdown of Ppm1b enhanced
the NF-κB p65 phosphorylation in HeLa-hRip3 cells (Supplementary
Fig. 5h). Besides, spontaneous and TNF (TNF plus Smacmimetic plus
zVAD (TSZ; ref. 13))-induced necroptosis in HeLa-hRip3 cells was
also enhanced by Ppm1b knockdown (Supplementary Fig. 5i). The
effects of IKKβ inhibitors were the same as what was observed in L929
cells (Supplementary Fig. 5i). These data again indicate that the effects
of Ppm1b on Rip3 and IKKβ are independent of each other. Different
from L929 and HT-29 cells, the two functions of Ppm1b in HeLa-
hRip3 cells coexist. As Ppm1b depletion promotes necroptosis, the
Ppm1b–Rip3 pathway seems to be more dominant than the Ppm1b–
IKKβ pathway in HeLa-hRip3 cells. We also measured the serum IL-6
levels and found that they were comparable in TNF-treated Ppm1bd/d
and WT mice (Supplementary Fig. 5j), which suggested that the
Ppm1b–Rip3 pathway might be the predominant one in vivo.
Ppm1b suppresses Mlkl recruitment to the necrosome on TNF
stimulation
As Rip3 phosphorylation is essential for the Rip3–Mlkl interaction
but not the Rip1–Rip3 interaction13,19,40, we tested whether Ppm1b
affects the interaction of Rip1–Rip3, Rip3–Rip3 and Rip3–Mlkl by co-
immunoprecipitation in 293T cells and found that Ppm1b-L attenu-
ated the interaction between Rip3 and Mlkl, but not the interaction
between Rip1 and Rip3 or Rip3 and Rip3 (Fig. 5a–c). To analyse the
recruitment of Mlkl to the necrosome in TNF-stimulated cells, we
used Rip3 KO L929 cells reconstituted with Flag–Rip3 (Rip3-KO–
Flag–Rip3) because Rip3-KO–Flag–Rip3 cells behave similarly toWT
L929 cells in necroptosis and the Flag tag facilitates immunoprecipi-
tation with the advantage of specific anti-Flag monoclonal antibody.
Whereas knockdown of Ppm1b did not affect the assembly of the
necrosome, as we were able to detect similar levels of Rip1 and
Fadd proteins in the immunoprecipitates of Flag–Rip3 in control and
Ppm1b knockdown cells after TNF stimulation (Fig. 5d), the recruit-
ment of Mlkl to Flag–Rip3-containing necrosome was significantly
increased in Ppm1b knockdown compared with control cell. It is
unclear howPpm1b is regulated, as we observed consistent association
of Ppm1b with Rip3 before and after TNF stimulation in L929 cells
(Fig. 5e) and translocation of both Ppm1b and Rip3 to a heterotypic
membrane fraction on TNF treatment41 (Fig. 5f). Nonetheless, these
data demonstrate that Ppm1b-mediated dephosphorylation of Rip3
impairs Rip3-mediated recruitment of Mlkl to the necrosome.
Ppm1a does not regulate necroptosis
Protein phosphatase 1A (Ppm1a) is the closest homologue of Ppm1b.
However, knockdown of Ppm1a neither caused spontaneous cell death
nor changed the sensitivity of L929 cells to TNF-induced cell death
(Fig. 6a–c). Knockout of Ppm1a by CRIPSR-Cas9 technology also did
not sensitize L929 cells to TNF killing (Fig. 6d). Double knockdown of
Ppm1a and Ppm1b did not exhibit an additive effect on spontaneous
necroptosis or TNF-induced cell death compared with Ppm1b single
knockdown (Fig. 6e–g). The lack of effect on necroptosis could be due
to the nuclear localization of Ppm1a (ref. 42), because Ppm1b andRip3
were found in the cytosol fraction (Fig. 6h).
Ppm1b protects mice from TNF-induced caecum damage
through dephosphorylating Rip3
TNF-induced necroptosis is essential for TNF-induced systemic
inflammatory response syndrome (SIRS) asRip3KOmice are resistant
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to TNF-induced death32,43,44. Littermates of WT and Ppm1bd/d mice
were injected intravenously with mouse TNF, with Ppm1bd/d mice
being more sensitive to TNF-induced death than WT mice (Fig. 7a).
An underlying mechanism of this in vivo result is likely to be that
Ppm1b suppresses TNF-induced necroptosis in this mouse model.
However, Ppm1b has been reported to negatively the regulate the
NF-κB pathway35, which might also affect TNF-induced SIRS. We
examined Ppm1bd/d Rip3−/− mice and found that the effect of Ppm1b
deficiency on TNF-inducedmouse death was completely prevented by
Rip3 knockout (Fig. 7b). Thus, the dephosphorylation of Rip3 should
be the in vivo function of Ppm1b in TNF-treated mice.
To better understand the role of Ppm1b in vivo, we first analysed
necroptosis-mediated tissue injury in TNF-treated mice. Unlike in
previous reports43,44, we did not find that Rip3 deletion affects TNF-
induced injuries in liver and kidney (Supplementary Fig. 6). Among
spleen, thymus, small intestine, liver, kidney, heart, lung, pancreas
and caecum, caecum was the only organ whose injury was attenuated
by Rip3 knockout (Fig. 7c,d and Supplementary Fig. 6). It is worth
noting that caecum was described as particularly sensitive to TNF-
induced injury in the report of the first TNF-SIRS model45. We
then analysed the effect of Ppm1b and found that TNF-induced
caecum damage was enhanced in Ppm1bd/d mice (Fig. 7e,f). Analysis
of the caecum lysate showed that TNF-induced phosphorylation
of Rip3 in Ppm1bd/d was higher than that in WT mice (Fig. 7g).
Moreover, the enhanced caecum damage in TNF-treated Ppm1bd/d
mice was completely prevented by Rip3 knockout (Fig. 7h,i). These
data further support that Ppm1b functions in restricting necroptosis
by dephosphorylating Rip3 in vivo.
DISCUSSION
In this study we identified a Rip3 phosphatase that negatively
regulates Rip3-dependent spontaneous andTNF-induced necroptosis.
Although the interaction of Ppm1b with Rip3 in the resting stage
explains the role of Ppm1b in preventing spontaneous necroptosis,
how Ppm1b is regulated during TNF-induced necroptosis is unclear.
The expression level and the cytosolic localization of Ppm1b did
not change during the course of TNF stimulation. Protein kinase A
(PKA) was shown to regulate protein stability of Ppm1b (ref. 46),
but activation of PKA by forskolin treatment did not change the
protein abundance of Ppm1b in L929. As Ppm1b can be activated
by fatty acids in vitro47 and Ppm1b translocated to the heterotypic
membrane fraction on TNF treatment, whether Ppm1b activity was
increased in the lipid-enriched fraction is interesting to know but
technically inaccessible at this moment. Consistent association with
its substrates has been observed in many phosphatases, including
protein phosphatase 1D (also termed as Wip1), which interacts with
ataxia-telangiectasia mutated kinase (ATM) before and after ionizing
radiation and regulates the ATM-dependent signalling pathways48.
It was shown that gene deletion of Ppm1b led to early pre-
implantation lethality in mice31. Although Rip3 knockout can rescue
spontaneous necroptosis in Ppm1b knockdown cells, Rip3 KO cannot
rescue the lethality of Ppm1b gene deletion. A Rip3-independent
function of Ppm1b should be responsible for the normal development
through the period of pre-implantation. The identification of Ppm1b
as a Rip3 phosphatase is encouraging because it not only advances
our understanding of the necroptosis pathway but also provides a
tool to manipulate necroptosis in vitro and in vivo. The information
presented in this report could be useful in exploring the contribution
of necroptosis to various physiopathological conditions. 
METHODS
Methods and any associated references are available in the online
version of the paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Antibodies and reagents. Anti-mRip3, p-Rip3, Fadd and Mlkl antibodies were
described previously19. Anti-Ppm1b antibody was raised in rabbit using GST-tagged
full-length human Ppm1b-L as the antigen. Anti-human Rip3 (ab72106, dilution
1:1,000) and anti-Ppm1a (ab14824, dilution 1:1,000) antibodies were from Abcam.
Anti-Flag (F7425, dilution 1:500), Myc (A7470, agarose affinity gel) andHA (A2095,
agarose affinity gel) antibodies were obtained from Sigma. Anti-Myc (sc-40, dilution
1:500), HA (sc-805, dilution 1:500) and anti-β-actin (sc-47778, dilution 1:10,000)
antibodies were obtained from Santa Cruz Biotechnology. Anti-Rip1 (610459,
dilution 1:1,000) antibody was obtained from BD Biosciences. Anti-Gapdh (60004-
1-Ig, dilution 1:2,000) and anti-Canx (10427-2-AP, dilution 1:500) antibodies
were from Proteintech. Anti-p-p65 (3033s, dilution 1:1,000), p65 (8242s, dilution
1:200), p-p38 (9216S, dilution 1:1,000), p38 (9212s, dilution 1:200) and H3 (9715,
1:5,000) antibodies were obtained from Cell Signaling Technology. Mouse TNFα
was purchased from eBioscience. zVAD was obtained from Calbiochem. Propidium
iodide (PI), 4-hydroxytamoxifen (4-OHT) and Protease Inhibitor Mix were from
Sigma. λ-phosphatase (λ-Ppase) was from NEB. AP21967 (A/C Heterodimerizer)
was obtained from ARIAD Pharmaceuticals.
Plasmids. Ppm1b-L and S (NM_001159496 and NM_011151) were amplified from
mouse cDNA and cloned into pBOBI or pLV lentivirus vector with no tag or
C-terminally tagged by the Exo III-assisted ligase-free cloning method. Deletion
mutants and point mutations of Ppm1b and Rip3 were introduced using standard
PCR or two rounds of PCR.
RNA interference. All lentiviral-shRNAs were constructed into pLV-H1-EF1α-
puro vector following the manufacturer’s instruction (Biosettia). The indicated
shRNA target sequences are: Ppm1b no. 1: 5′-ACAAGTGTGTGGATGGCAA-3′ ;
Ppm1b no. 2: 5′-GGAGAGTAGAAATGGAAGA-3′ ; Ppm1b-L no. 1: 5′-GGCTAG
AGCTGGCCTATAA-3′ ; Ppm1b-L no. 2: 5′-GAGGAGTGCTGAAAATATA-3′ ; P
pm1b-S no. 1: 5′-CTAAGGAAATACAGAGATA-3′ ; Ppm1b-S no. 2: 5′-TGCTGA
ACATGAAGAGTAA-3′; hPpm1b no. 1: 5′-CAGTGGGAGTTATGATTTC-3′; hPp
m1b no. 2: 5′-GGTGATTCACGTGCTGTTC-3′ ; Ppm1a no. 1: 5′-CCAAAGATGG
AGAAGCATA-3′; Ppm1a no. 2: 5′-GAAGAAACATGGTGCAGAT-3′ .
Lentivirus infection. For lentivirus production, 293T cells were transfected
with lentiviral vectors carrying cDNAs or shRNAs of interest (or its mutants)
and lentivirus-packing plasmids (PMDL/REV/VSVG) by the calcium phosphate
precipitation method. Twelve hours later, cell culture medium was changed and
the virus-containing medium was collected 36 h later. For infection, 1ml virus-
containing medium and 1.5 ml fresh medium containing 10 µgml−1 Polybrene were
added to cells plated in 6-well plates. The plates were centrifuged at 1,500g for 30min
and returned to the cell incubator. The infectious medium was changed 12 h later.
KOcell lines and cell culture.Rip1KO,Rip3KOandMlkl KOL929were described
previously17,19. Ppm1b, Ppm1a, TNFRI and IKKβ KO cell lines were generated
using the CRISPR/Cas9 technology30,49. Rip1–Rip3 DKO L929 cells were generated
by targeting Rip1 in Rip3 KO L929 cells. The targeting sequences are: Ppm1b-
5′-CTGGGAATGGTCTGCGTTA-3′ ; Ppm1a-5′-TGTAATCGAAATCCCCAA
-3′ ; Rip1-5′-AACCGCGCTGAGTGAGTTGG-3′ ; TNFRI-5′-GCTTCAACGGC
ACCGTGACA-3′ ; IKKβ-5′-CACCGTGACCGTTGACTAC-3′. Thioglycollate-
elicited peritoneal macrophages were obtained from eight-week-oldWT or Rip3KO
mice using a method described previously50. Primary WT and Ppm1bd/d MEF cells
were generated from day 14 embryos of the same litter of Ppm1b+/d heterozygous
breeding. The primary MEF cells were immortalized by infection with retrovirus
encoding E1A. Mouse BMDMs were differentiated in vitro from isolated bone
marrow cells. Bone marrow cells collected from mouse femurs and tibias were
incubated for seven days in DMEM containing 20% heat-inactivated FBS, penicillin,
streptomycin and 30% L929 conditionalmedium28. Three pairs of Ppm1bd/d andWT
mice were used to produce MEF cells and BMDM cells in this work, respectively.
HT-29 cells were cultured in McCoy’s 5A culture medium (Invitrogen); L929, HEK-
293T, NIH3T3-A, NIH3T3-N, HeLa, peritoneal macrophage, J774 and MEF cells
were cultured in DMEM. All media were supplemented with 10% FBS (vol/vol),
2mM L-glutamine, 100 IU penicillin and 100mgml−1 streptomycin at 37 ◦C in a
humidified incubator containing 5% CO2.
Cell death assay.Cell death was analysed bymeasuring plasmamembrane integrity
to incorporate propidium iodide (PI). To measure the spontaneous cell death, PI
(5 µgml−1) was directly added in the medium and incubated for 10min. Total
cell numbers and PI-positive cells were counted under an inverted fluorescence
microscope. Four fields of cells for each sample (more than 1,000 cells) were counted.
The data are expressed as the percentage of PI-positive cells per total cells counted.
For TNF-induced cell death, cells were trypsinized and re-plated in 12-well plates
to remove dead cells 12 h before TNF treatment. Cells were treated with TNF for the
indicated time and then trypsinized, collected by centrifugation, and resuspended
in PBS containing 5 µgml−1 PI. The level of PI incorporation was quantified by
flow cytometer (BD, FACSCalibur). Cell size was evaluated by forward-angle light
scattering. PI-negative cells with a normal size were considered as living cells.
Apoptosis of MEF cells was measured by Annexin V staining according to the
manufacturer’s instructions (Biotium).
Mass spectrometric analysis. Rip3 KO L929 cells expressing Flag–Rip3 or empty
vector (control) were treated with or without TNF for 4 h. Protein complex was
immunoprecipitated with M2 beads, and eluted with 3X FLAG peptides. Proteins
from elution were precipitated by addition of TCA to 20% (vol/vol) and incubated
on ice for at least 30min, followed by centrifugation at 16,000g for 10min at 4 ◦C.
Protein pellets were washed with ice-cold acetone and dried briefly by vacuum
centrifugation and then resuspended in 8M urea in 50mM NH4HCO3. Cysteines
were reduced (5mM dithiothreitol, 30min) and alkylated (15mM iodoacetamide,
30min in dark), and the urea concentration was reduced to 1.33 M by dilution
with 50mMNH4HCO3. Proteins were digested overnight at 37 ◦C by the addition of
trypsin at a ratio of protein/trypsin (1:100). Formic acid was added to 1% (vol/vol),
peptides were loaded onto a STAGEtip for desaltion, and peptides were eluted
directly into inserts with 70% acetonitrile/1% formic acid. The tryptic peptides
were analysed on an AB Sciex TripleTOF 5600 mass spectrometer interfaced to an
Eksigent NanoLC Ultra 2D Plus HPLC system, essentially as previously described51.
Peptides were chromatographed using a 60-min gradient from2–35% (bufferA 0.1%
(vol/vol) formic acid 2% (vol/vol) acetonitrile, buffer B 0.1% (vol/vol) formic acid,
98% (vol/vol) acetonitrile) after injection onto a 15-cm emitter (New Objective)
packed with New Objective C18 3-µm. MS1 spectra were collected in the range
350–1,250m/z for 250ms, and the 20 most intense precursors with charge state
2–5 were selected for fragmentation; MS2 spectra were collected in the range
100–1,800m/z for 100ms. For each IP sample, triple injections were performed to
achieve depth identification. All wiff files were searched against the mouse Uniprot
proteome database (July 2013) appended with common contaminants and reversed-
sequence decoys (101,970 sequence including decoys) using ProteinPilot V4.5 beta.
‘Iodoacetamide’ was selected for Cys alkylation, and ‘Trypsin’ as protease, and Search
Effort was set as ‘Rapid ID’. Proteins were filtered with 5% FDR. Phosphatases
identified in either TNF-treated or untreated samples were selected as potential
Rip3 phosphatases.
Immunoprecipitation and immunoblotting. Cells were lysed with lysis buffer
(20mM Tris-HCl, pH 7.5, 150mMNaCl, 1mMNa2EDTA, 1mM EGTA, 1% Triton
X-100, 2.5mM sodium pyrophosphate, 1mM β-glycerophosphate, 1mM Na3VO4)
on ice for 15min. Cell lysates were then centrifuged at 20,000g for 30min. The
supernatant was immunoprecipitated with antibody-coupled beads at 4 ◦C for 3 h or
overnight. After the immunoprecipitation, the beads were washed four times in lysis
buffer and the immunoprecipitated proteinswere subsequently eluted by SDS sample
buffer. For endogenous Rip3 immunoprecipitation, anti-Rip3 antibody was coupled
to beads by the GlycoLink Immobilization Kit according to the manufacturer’s
instructions. The luminescent signals of immunoblotting were analysed using
an ImageQuant LAS 4000 Scanner (GE Healthcare) or X-ray film.
In vitro phosphatase assay. GST–Ppm1b and GST–R179G were expressed and
purified from Escherichia coli Flag–mRip3 protein was immunoprecipitated using
anti-Flag beads from cell lysates of transfected 293T cells and eluted with ×3
Flag peptide. GST–Ppm1b, GST–R179G and GST were incubated with Flag–Rip3
in buffer (20mM HEPES, 20mM MgCl2, 0.03% β-mercaptoethanol) at 30 ◦C for
30min with gentle shaking. The reactions were stopped by the addition of ×2 SDS
sample buffer followed by boiling for 5min.
For λ-phosphatase treatment, endogenous Rip3 was immunoprecipitated by
Rip3 antibody-coupled beads and washed three times with ×1 phosphatase buffer
(50mM HEPES (pH 7.5), 100mM NaCl, 2mM dithiothreitol, 0.01% Brij 35,
1mM MnCl2). The immunoprecipitate was then divided into two parts. One was
augmented with 200 units of λ-phosphatase (NEB) but the other was mock treated.
After incubation at 30 ◦C for 30min with gentle shaking, the reactions were stopped
by the addition of×2 SDS sample buffer followed by boiling for 5min.
Chemical-induced forced Rip3–Rip3 interaction and Mlkl oligomerization.
To generate the FKBP–Rip3RHIM and FRB–Rip3RHIM constructs the Rip3RHIM
(QIG449-451AAA)mutant was fused to the C terminus of the FKBP domain (FK506
binding protein) andFRBdomain (domain ofmTORwith a pointmutationT2098L).
Plasmids used as templates containing FKBP and the mutant FRB domain were
obtained from the ARGENT Regulated Heterodimerization Kit kindly provided
by ARIAD (now iDimerizeTM Inducible Heterodimer System by Clontech). The
interaction of FKBP and FRB fusion proteins can be induced by a rapamycin
analogue AP21976. The FKBP–Rip3RHIM and FRB–Rip3RHIM were introduced to
Rip1–Rip3 DKO L929 cells by co-infection of lentiviral vectors. To evaluate the
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Ppm1b function, these cells were then co-infected with lentiviral vectors encoding
Ppm1b-L and Ppm1b-S, or infected with empty vectors. As the infection efficiency
was nearly 100% (evidenced by parallel infection or co-infection with lentiviral-
GFP), it was unnecessary to select cells that express both proteins. Twenty-four hours
after infection, AP21976 (250 nM) was added to induce Rip3–Rip3 interaction. Cell
death was analysed 2 h later.
The chemical-induced Mlkl oligomerization has been described previously17.
Briefly,Mlkl was fused to theN terminus of oestrogen-induced homodimerization of
the hormone binding domain (HBD) with a G521R mutation (termed Mlkl–HBD).
A synthetic antioestrogen 4-hydroxytamoxifen (4-OHT) can induce dimerization
of the HBD fusion protein. Mlkl–HBD was introduced to Mlkl KO L929 cells by
lentiviral vector. Thirty-six hours after infection, 4-OHT (1 µM)was added to induce
Mlkl oligomerization. Cell death was analysed 2 h later.
Generation of Ppm1bd/d and Ppm1bd/d Rip3−/− mice. The mouse Ppm1b-
disrupted embryonic stem cell clone (AW0406) with a retrovirus vector based on the
gene-trap technology employed at Sanger Institute was purchased from the Mutant
Mouse Regional Resource Center (MMRRC, University of California Davis). The
exact gene-disruption position was determined by 3′ RACE and genomic DNA
PCR. Ppm1b+/d embryonic stem cells were injected into C57BL/6 blastocysts, and
chimaeric male mice were bred to C57BL/6 wild-type female mice. The resulting
Ppm1b+/d offspring were bred to C57BL/6 mice for more than ten generations.
Genotyping was carried out by genomic DNA PCR with the following three
primers: P1-5′-TCTCGTTGCATTTAGTGTTTACCACTGT-3′ (forward sequences
in Ppm1b genome); P2-5′-GGCTTCTGAATAACCGAATTCAAGG-3′ (reverse
sequences in Ppm1b genome); P3-5′-CTCCCTGGCCTCCAGACAAGTAGA-3′
(reverse sequences in retrovirus intron). P1 and P2 are for wild-type allele PCR to
produce a 217-bp band, and P1 and P3 are for mutated allele PCR to produce a
310-bp band.
Rip3−/− mice were generated by the transcription activator-like effector
nucleases (TALENs)-mediated gene-disruption method in a C57BL/6 background,
as described previously28. Genotypes were confirmed by tail-snip PCR. Rip3−/− and
Ppm1b+/d were subsequently intercrossed.
SIRS mice model. Mice were housed in a specific pathogen-free environment.
All experiments were conducted in compliance with the regulations of Xiamen
University. Six- to eight-week-old female mice (average weight approximately 20 g)
were injected intravenously with 15 µg TNF (75 µgml−1) diluted in endotoxin-
free PBS. Mice injected with PBS alone were included as a control. Animals were
under permanent observation and survival was checked every 30min. Littermates of
Rip3−/− and WT, Ppm1bd/d and WT, Ppm1bd/dRip3−/− and Ppm1b+/+ Rip3−/− mice
were used in the experiments. The investigator was blinded to allocation when the
mice were injected with TNF and when mice deaths were counted.
In total, 44 pairs of Rip3−/− and WT mice, 79 pairs of Ppm1bd/d and WT mice,
and 26 pairs of Ppm1bd/dRip3−/− and Ppm1b+/+Rip3−/− mice were used in these
experiments and the subsequent histology analyses.
Histology.After animals were euthanized, tissues of different organs were collected
immediately, and fixed in 10% neutral buffered formalin for 24 h. The fixed tissues
were dehydrated in ethanol, cleared in xylene, and embedded in paraffin blocks.
Five-micrometre sections were cut and mounted on adhesion microscope slides
(ZSGB-BIO), and then stainedwith haematoxylin and eosin (H&E) or periodic acid–
Schiff (PAS) for analyses.
The degree of caecum damage was assessed by a method described previously52.
Then the sum of the average scores of four fields per sample was calculated as the
caecum damage score. Representative images were captured and processed using
identical settings in the Leica DM2500 at Xiamen University.
The investigators were blinded to allocation when the histology experiments
were performed and tissue damage was scored.
IL-6 level determination. Following the manufacturer’s instructions, the
supernatants of the cell culture were collected and the IL-6 level was measured by
commercial ELISA kits for mouse IL-6 (R&D). For the in vivo SIRS model, the sera
were collected before (0 h) and after (2 h, 4 h) TNF injection, and were analysed for
their IL-6 levels by ELISA kits.
Isolation of nucleus and cytosol. Cells were trypsinized, collected by
centrifugation, and washed with pre-cold PBS three times. Then cells were
resuspended in Buffer A (10mM HEPES, pH 7.9; 1.5mM MgCl2; 10mM KCl;
300mM sucrose; 0.5% NP-40) for 10min on ice with gentle tapping. Cell lysate was
then centrifuged at 1,000g for 5min. The suspension (cytosol) was collected and
centrifuged further at 1,000g for 10min to get rid of nucleus contamination; the
pellets (nucleus) were resuspended and washed with Buffer A twice.
Subcellular fractionation. L929 cells were fractionated and heavy membrane
(HM), mitochondria (Mito) and heterotypic membrane (HeteroM) were isolated as
described previously41. Briefly, approximately 3× 108 cells were washed with cold
PBS and collected into 50ml tubes. Cells were homogenized by glass homogenizer
(Kontes) in homogenization buffer (225mM mannitol, 75mM sucrose, 0.1mM
EGTA and 30mM Tris–HCl (pH 7.4)). The lysate was centrifuged at 800g to
remove nuclei. The supernatant was centrifuged at 100,000g for 10min at 4 ◦C and
the subsequent pellet was collected as HM. For further purification, HM was
resuspended and loaded on 20% Percoll and centrifuged at 10,000g for 30min at
4 ◦C. Mitochondria were recovered from the bottom of the gradient; the heterotypic
membranes were collected from the upper gradient. Each fraction was quantified
and indicated proteins were analysed by western blot.
Statistical evaluation. Statistical analysis was performed with Prism software
(GraphPad Software). Data are expressed as means ± s.e.m. Two-tailed Student’s
t-test was used to compare differences between treated groups and their paired
controls. Mice survival is presented as a Kaplan–Meyer plot and compared by
log-rank (Mantel–Cox) Test. To evaluate the caecum damage between the two
genotypes, a Wilcoxon signed-rank test was performed. Differences in compared
groups were considered statistically significantly different with P values lower than
0.05; #: P<0.05; ##: P<0.01; ###: P<0.001.
No statistical method was used to predetermine sample size. The experiments
were not randomized. The investigators were blinded to allocation during the SIRS
mouse model experiments and histology experiments (see the SIRS mice model and
Histology section above). For other experiments, the investigators were not blinded
to allocation during experiments and outcome assessment.
49. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339,
823–826 (2013).
50. Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine
macrophages. Curr. Protoc. Immunol. 11 (2008).
51. Wu, X. et al. Investigation of RIP3-dependent protein phosphorylation by quantitative
phosphoproteomics. Mol. Cell Proteomics 11, 1640–1651 (2012).
52. Coburn, B., Li, Y., Owen, D., Vallance, B. A. & Finlay, B. B. Salmonella enterica
serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a
mouse model of infectious enterocolitis. Infect. Immun. 73, 3219–3227 (2005).
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Supplementary Figure 1 Ppm1b interacts with Rip3. (a) Ppm1b interacts 
with Rip3 in resting stage in L929 cells. Rip3-KO-Flag-Rip3 L929 cells 
were lysed and the cell lysates were immunoprecipitated with anti-HA 
(IP: HA) and anti-Flag (IP: Flag) antibodies. Both the cell lysate (Input) 
and immunoprecipitates were analyzed by immunoblotting with indicated 
antibodies. The vertical line represents a splice mark. The samples 
were obtained and processed in the same experiment, and the gels/
blots were processed in parallel. (b) Both Ppm1b-L and Ppm1b-S co-
immunoprecipitate with Rip3 in 293T cells. Myc-Rip3 was coexpressed 
with Flag-tagged Ppm1b-L, Ppm1b-S or empty vector. Then co-
immunoprecipitation experiments were performed with anti-Flag antibody. 
Both the immunoprecipitates and lysates were analyzed by immunoblotting 
with indicated antibodies. (c) Ppm1b selectively interacts with Rip3 but 
not the other necrosome components in 293T cells. Flag-Ppm1b-L was 
coexpressed with HA-tagged proteins as indicated. Co-immunoprecipitaton 
experiments were performed with anti-HA antibody and analyzed as in (b) 
(d) Schematic of the domain structures of Ppm1b-L and Ppm1b-S and 
Rip3. (e) The phosphatase domain of Ppm1b interacts with Rip3. Myc-
Rip3 was coexpressed with Flag-tagged full length and truncated Ppm1b 
in 293T cells. Then co-immunoprecipitation experiments were performed 
as in (b). Ppm1b-L-PD: Ppm1b-L phosphatase domain; Ppm1b-L-CD: 
Ppm1b-L C-terminal domain. (f) The kinase domain of Rip3 interacts with 
Ppm1b. Flag-Ppm1b-L-PD was coexpressed with Myc-tagged full length and 
truncated Rip3 in 293T cells. Then co-immunoprecipitation experiments 
were performed with anti-Myc antibody and analyzed as in (b). Rip3-KD: 
Rip3 kinase domain; Rip3-CD: Rip3 C-terminal domain. Data shown were 
representative of two or more independent experiments. Uncropped images 
of blots are shown in Supplementary Figure 7.
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Supplementary Figure 2 Related to Figure 2. (a) The protein amounts in 
Ppm1b knocked down and control L929 cells were analyzed by immunoblotting 
with indicated antibodies.  Related to Figure 2a. (b) Ppm1b-S, Ppm1b-L and 
both isoforms were knocked down with isoform-specific shRNAs in L929 
cells.  Left, 48 hours later, spontaneous cell death was measured. Right, the 
protein amounts were analyzed by immunoblotting with indicated antibodies. 
Results shown were mean ± s.e.m.; n = 3000 cells pooled from 3 independent 
experiments. (c) The protein amounts in Ppm1b knocked down and control 
cells were analyzed by immunoblotting with indicated antibodies.  Related to 
Figure 2c. (d) The protein amounts in WT and Rip3 KO L929 cells knocked 
down with shPpm1b or control shRNAs were analyzed by immunoblotting with 
indicated antibodies. Related to Figure 2f. (e) The protein amounts in WT and 
Rip3 KO mouse peritoneal macrophage cells knocked down with shPpm1b or 
control shRNAs were analyzed by immunoblotting with indicated antibodies. 
Related to Figure 2g. For Figure a,c,d,e, data shown were representative of two 
or more independent experiments. The asterisk (*) denotes a nonspecific band. 
Statistics source data for this figure can be found in Supplementary Table 2. 
Uncropped images of blots are shown in Supplementary Figure 7.
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Supplementary Figure 3 Related to Figure 3. (a) Ppm1b was knocked down 
in Rip3 KO L929 cells reconstituted with Rip3-WT, Rip3 phosphorylation 
deficient mutant (Rip3-2A) mutant and Rip3 RHIM domain mutant 
(Rip3RHIM). The cells were lysed and subjected to immunoblotting with 
indicated antibodies. Related to Figure 3b. (b) Ppm1b was knocked down 
in WT and Rip1 KO L929 cells. The cells were lysed and subjected to 
immunoblotting with indicated antibodies. The vertical line represents a splice 
mark. The spliced images were from the same blot.  Related to Figure 3c. 
(c) WT Rip3 and Rip3RHIM were introduced into Rip1 KO and WT L929 cells 
by lentiviral vectors. The cells were lysed and subjected to immunoblotting 
with indicated antibodies. Related to Figure 3d. (d) Ppm1b was knocked 
down in WT and Mlkl KO L929 cells. The cells were lysed and subjected to 
immunoblotting with indicated antibodies. Related to Figure 3h. (e) TNFR1 
KO and WT L929 cells were infected with lentivirus encoding shPpm1b or 
control. Left, spontaneous cell death was analyzed 48 hours later. n = 3000 
cells pooled from 3 independent experiments. Right, TNFR1 KO and WT L929 
cells were treated with or without TNF for 12 hours. Cell death was analyzed. n 
= 3 independent experiments. Results shown were mean ± s.e.m.; ##P<0.01; 
###P<0.001. For Figure a-d, data shown were representative of two or more 
independent experiments. The asterisk (*) denotes a nonspecific band. 
Statistics source data for this figure can be found in Supplementary Table 2. 
Uncropped images of blots are shown in Supplementary Figure 7.
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Supplementary Figure 4 Ppm1b targets TNF-induced necroptosis but not 
apoptosis. (a-b) L929 cells were infected with lentivirus encoding shPpm1b 
or control, or not infected (Mock). 48 hours later, (a) the cells were treated 
with TNF (10 ng/ml) for indicated time periods and cell death was analyzed 
by flow cytometer; (b) the cells were treated with different doses of TNF 
as indicated for 6 hours and cell death was analyzed. n = 3 independent 
experiments. (c) Ppm1b does not affect TNF-induced apoptosis in NIH3T3-A 
cells. Ppm1b was knocked down in NIH3T3-A cells. Left, 48 hours later, 
the cells were treated with or without TNF (100 ng/ml) for 24 hours and 
cell death was analyzed. n = 3 independent experiments. Right, the cell 
lysates were analyzed by immunoblotting with indicated antibodies. (d) 
Both Ppm1b-L and S isoforms restrict TNF-induced necroptosis in L929. 
Ppm1b-S, Ppm1b-L or both isoforms were knocked down with isoform 
specific shRNAs in L929 cells.  48 hours later, the cells were treated with 
or without TNF (10 ng/ml) for 6 hours and cell death was measured. n = 
3 independent experiments. (e) Ppm1b KO L929 cells were infected with 
different doses of lentivirus encoding Ppm1b-L and Ppm1b-S as indicated, 
or not infected (Mock infection). Then the cells were treated with TNF 
(10 ng/ml) for 6 hours and cell death was analyzed. n = 3 independent 
experiments. (f) Ppm1b does not affect the TNF-induced p65 and p38 
phosphorylation. Ppm1b was knocked down with shRNA in L929 cells. 48 
hours later, the cells were treated with TNF (10 ng/ml) for indicated time. 
The cell lysates were analyzed by immunoblotting with indicated antibodies. 
(g) The Ppm1b-β-geo fusion mRNA sequences in Ppm1bd/d mice were 
determined by 3’ RACE. For Figure a-e, results shown were mean ± s.e.m.; 
#P<0.05; ##P<0.01; ###P<0.001; N.S.: no significant difference. For Figure 
f, data shown were representative of two independent experiments. The 
asterisk (*) denotes a nonspecific band. Statistics source data for this figure 
can be found in Supplementary Table 2. Uncropped images of blots are 
shown in Supplementary Figure 7.
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Supplementary Figure 5 The regulation of necroptosis by Ppm1b is 
independent of NF-κB pathway. (a) HeLa cells were infected with lentivirus 
encoding sh-hPpm1b or control. 48 hours later, the cells were treated with 
hTNF (30 ng/ml) for indicated time and subjected to immunoblotting with 
indicated antibodies. (b) HT29 cells were analyzed as in (a). (c) L929 cells 
were infected with lentivirus encoding shPpm1b or control, or not infected 
(Mock). 48 hours later, the cells were treated with TNF for indicated time and 
the IL-6 level of the cell culture supernatant was analyzed by ELISA. n = 3 
independent experiments. (d) Left, L929 cells were infected with lentivirus 
encoding shPpm1b or control, or not infected (Mock). 5 hours after infection, 
the cells were treated with DMSO, TPCA-1 (1μM) or IMD 0354 (5μM). 48 
hours later, spontaneous cell death was analyzed. Middle, IKKβ KO and WT 
L929 cells were infected with lentivirus encoding shPpm1b or control, or 
not infected. 48 hours later, spontaneous cell death was analyzed. Right, 
the IKKβ protein amount in IKKβ KO and WT L929 cells was determined by 
immunoblotting. n = 3000 cells pooled from 3 independent experiments. (e) 
Left, the cells were treated as in (d, left), except that the cells were treated 
with TNF for 5 hours and the TNF-induced cell death rather than spontaneous 
cell death was analyzed 48 hours after infection. Right, the cells were treated 
as in (d, middle), except that the cells were treated with TNF for 5 hours and 
TNF-induced cell death rather than spontaneous cell death was analyzed 48 
hours after infection. n = 3 independent experiments. (f) L929 cells were 
pretreated with DMSO, TPCA-1 or IMD 0354 for 2 hours followed by treatment 
with TNF for indicated time. The IL-6 level of the cell culture supernatant 
was analyzed by ELISA. n = 3 independent experiments.  (g) L929 cells were 
infected with lentivirus encoding shPpm1b or control, or not infected. 48 
hours later, the cells were pretreated with DMSO or 5z-7 (1 μm) for 2 hours 
followed by treatment with TNF for 5 hours. Then the cell death was analyzed. 
n = 3 independent experiments. (h) HeLa cells stably expressing human Rip3 
(HeLa-hRip3) were analyzed as in (a). (i) HeLa-hRip3 cells were infected with 
lentivirus encoding sh-hPpm1b or control, or not infected. Spontaneous cell 
death and hTNF (30 ng/ml) +Smac mimetic (100 nM) +zVAD (20 μM) (TSZ)-
induced cell death were analyzed as in (d, left) and (e, left). n = 3 independent 
experiments. (j) Littermates of Ppm1bd/d and WT mice were injected with 
TNF (15 μg) via the tail vein. Then the serum IL-6 level was analyzed by 
ELISA at different time points as indicated. n=4 mice for each group in single 
experiment where two independent experiments were performed to assess 
reproducibility. ND: not detectable. For Figure c-g,i,j, results shown were mean 
± s.e.m.; #P<0.05; ##P<0.01; ###P<0.001;. For Figure a,b,h, data shown 
were representative of two or more independent experiments. Statistics source 
data for this figure can be found in Supplementary Table 2. Uncropped images 
of blots are shown in Supplementary Figure 7.
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Supplementary Figure 6 TNF induces tissue damage in different 
organs of WT and Rip3-/- mice. Littermates of WT and Rip3-/- mice 
were injected with TNF (15 μg) via the tail vein for indicated time. The 
sections of kidney were analyzed by PAS staining while those of the 
other organs were analyzed by H&E staining. The representative images 
were shown (n=5 mice of each genotype at 12 hour time point; n=3 
mice of each genotype at 0 hour time point.). Scale bar: 50 or 100 μm 
as indicated.
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Supplementary Figure 7 Uncropped images of blots in Figure 1-7 and Supplementary Figure 1-6.
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Supplementary Table Legends
Supplementary Table 1 The mass spectrometric data of Rip3 immunocomplex. Rip3 KO L929 cells were reconstituted with Flag-Rip3 to generate Rip3-
KO-Flag-Rip3 L929 cells. Upon TNF treatment for 5 hours, these cells were lysed and subjected to immunoprecipitation with anti-Flag antibody. Then 
the immunocomplex was analyzed by mass spectrometry and results were listed below. See “Methods” for detail.  Protein score: A measure of the protein 
confidence for a detected protein, calculated from the peptide confidence for peptides. The higher the value is, the more confidently the protein exists in the 
sample. %Cov (coverage): The percentage of matching amino acids from identified peptides having confidence greater than 0, divided by the total number of 
amino acids in the sequence. %Cov(95)(coverage): The percentage of matching amino acids from identified peptides having confidence greater than 95%, 
divided by the total number of amino acids in the sequence. Peptides(95%): The number of the unique, high confident (>95%) peptides in the detected 
protein.
Supplementary Table 2 The statistics source data for Figures and Supplementary Figures. 
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